"Febrile Neutropenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fever accompanied by a significant reduction in the number of NEUTROPHILS.
| Descriptor ID |
D064147
|
| MeSH Number(s) |
C15.378.553.546.184.564.750
|
| Concept/Terms |
Febrile Neutropenia- Febrile Neutropenia
- Febrile Neutropenias
- Neutropenia, Febrile
- Neutropenias, Febrile
|
Below are MeSH descriptors whose meaning is more general than "Febrile Neutropenia".
Below are MeSH descriptors whose meaning is more specific than "Febrile Neutropenia".
This graph shows the total number of publications written about "Febrile Neutropenia" by people in this website by year, and whether "Febrile Neutropenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Febrile Neutropenia" by people in Profiles.
-
Huang GX, Merz LE, Mehta GD, Marquis KD, Besz K, Lynch DM, Cutler C, Castells MC. Preadmission Penicillin Allergy Evaluation Before Hematopoietic Stem Cell Transplantation Optimizes Febrile Neutropenia Treatment and Inpatient Resource Utilization. Transplant Cell Ther. 2024 11; 30(11):1112.e1-1112.e9.
-
Bhardwaj PV, Emmich M, Knee A, Ali F, Walia R, Roychowdhury P, Clark J, Sridhar A, Lagu T, Loh KP. Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study. Support Care Cancer. 2021 Oct; 29(10):5905-5914.
-
Atallah-Yunes SA, Kadado AJ, Haddadin F, Sawalha K, Hernandez-Montfort J, Ali SS. Impact of cardiovascular comorbidities on inpatient mortality in patients hospitalized with neutropenic fever. Support Care Cancer. 2021 Jan; 29(1):509-513.
-
Ben-Chetrit E, Eldaim MA, Bar-Meir M, Dodin M, Katz DE. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia. Int J Antimicrob Agents. 2019 Apr; 53(4):423-428.
-
Morita Y, Maeda Y, Yamaguchi T, Urase F, Kawata S, Hanamoto H, Tsubaki K, Ishikawa J, Shibayama H, Matsumura I, Matsuda M. Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial. Cancer Sci. 2018 Oct; 109(10):3209-3215.
-
Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, Castagnola E, Davis BL, Dupuis LL, Gaur AH, Tissing WJE, Zaoutis T, Phillips R, Sung L. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin Oncol. 2017 Jun 20; 35(18):2082-2094.
-
Robinson PD, Lehrnbecher T, Phillips R, Dupuis LL, Sung L. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials. J Clin Oncol. 2016 06 10; 34(17):2054-60.
-
Sanford D, Lo-Coco F, Sanz MA, Di Bona E, Coutre S, Altman JK, Wetzler M, Allen SL, Ravandi F, Kantarjian H, Cortes JE. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide. Br J Haematol. 2015 Nov; 171(4):471-7.